MIR4483: A Potential Drug Target and Biomarker (G100616162)
MIR4483: A Potential Drug Target and Biomarker
MIR4483, also known as interleukin-4 receptor 7 (IL-4R7), is a non-coding RNA molecule that plays a crucial role in the regulation of inflammation and immune responses. It is a key regulator of the interleukin-4 (IL-4) receptor, which is involved in the regulation of various cellular processes such as cell growth, differentiation, and inflammation. MIR4483 has been identified as a potential drug target and biomarker for various diseases, including cancer, autoimmune disorders, and respiratory diseases.
The IL-4 receptor is a transmembrane protein that is involved in the regulation of cellular responses to both intrinsic and extrinsic stimuli. It is composed of two subunits, IL-4R1 and IL-4R2, which are involved in the regulation of different signaling pathways. IL-4R1 is the receptor for the agonist, while IL-4R2 is the receptor for the antagonist. MIR4483 is a non-coding RNA molecule that is highly expressed in various tissues and cell types, including immune cells, tissues, and organs. It is composed of 29 amino acid residues and has a calculated molecular weight of 33.9 kDa.
MIR4483 is involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. It is a key regulator of the IL-4 signaling pathway, which is involved in the regulation of cellular responses to intracellular and extracellular stimuli. MIR4483 is a negative regulator of the IL-4R1 subunit, which means that it promotes the activity of the IL-4R1 subunit by inhibiting its phosphorylation. This interaction between MIR4483 and IL-4R1 is important for the regulation of cellular responses to agonists.
MIR4483 has been shown to play a crucial role in the regulation of cellular responses to various stimuli, including cytokines, which are signaling molecules that are produced by the immune system in response to the presence of foreign substances in the body. Cytokines, such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), and interleukin-6 (IL-6), are involved in the regulation of cellular responses to different stimuli, including infection, inflammation, and tissue repair. MIR4483 is involved in the regulation of the activity of these cytokines, which is important for the regulation of cellular responses to various stimuli.
MIR4483 has also been shown to play a role in the regulation of cellular responses to stress. Stress, including physical stress and chemical stress, can cause cellular responses that are essential for the survival of the cell. MIR4483 is involved in the regulation of cellular responses to stress, which is important for the regulation of cellular stress responses.
MIR4483 has also been shown to play a role in the regulation of cellular responses to various signaling pathways, including the TGF-beta signaling pathway. TGF-beta is a signaling pathway that is involved in the regulation of cellular responses to various stimuli, including cytokines. MIR4483 is involved in the regulation of the activity of TGF-beta, which is important for the regulation of cellular responses to various stimuli.
In conclusion, MIR4483 is a non-coding RNA molecule that plays a crucial role in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. It is a key regulator of the IL-4 signaling pathway and has been shown to play a role in the regulation of cellular responses to various stimuli, including cytokines, stress, and signaling pathways. As a potential drug target and biomarker, MIR4483 is a promising target for the development of new therapies for various diseases, including cancer, autoimmune disorders, and respiratory diseases.
Protein Name: MicroRNA 4483
The "MIR4483 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4483 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668
